SELECT MEDICAL HOLDINGS CORP SEM Cash Flow

Select medical holdings corp (SEM)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities
Net income
70,448	43,671	44,030	59,986	53,344	29,722	42,679	60,559	43,982	121,058	24,824	51,300	23,463	20,481	3,992	40,853	59,944	25,847	32,810	40,054	37,285	27,518	28,296	37,994	34,367	31,122	25,207	29,878	36,802	41,347	25,158	44,816	42,572	37,337	26,381	13,657	35,387
Adjustments to reconcile net income to net cash provided by operating activities:
Distributions from unconsolidated subsidiaries
8,479	6,613	2,461	3,276	7,872	4,987	2,904	6,466	1,364	5,464	3,609	6,022	4,911	4,331	4,106	3,734	8,305	2,155	11,762	24	28	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
51,752	52,504	52,941	54,993	52,138	52,633	50,527	51,724	46,771	40,367	38,772	38,333	42,539	37,424	37,165	36,205	34,517	34,313	31,472	21,848	17,348	17,345	17,584	17,196	16,229	16,520	16,163	15,907	15,802	16,147	15,537	15,428	16,199	18,751	17,545	17,999	17,222
Provision for expected credit losses
199	694	386	391	1,567	270	-475	17	85	78,577	169	-36	781	-51,059	17,677	17,517	16,397	16,129	18,287	12,286	12,670	12,110	10,357	11,115	11,018	9,994	9,262	8,846	9,321	7,452	11,199	10,029	10,375	11,345	11,709	13,943	14,350
Equity in earnings of unconsolidated subsidiaries
2,588	6,279	6,950	7,394	4,366	6,991	5,432	4,785	4,697	5,436	4,431	5,666	5,521	5,477	5,268	4,546	4,652	4,023	6,348	3,848	2,592	2,909	1,988	1,239	908	1,029	-179	568	1,058	1,321	1,167	2,752	2,465	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	2,516	0	72	412	0	0	0	6,527	0	10,853	0	773	-	-	-	-	0	0	0	-2,277	0	0	-17,280	-1,467	-	-	-	-	-	-	-	-
Gain on sale of assets and businesses
7,339	-28	-5	121	6,233	39	2,149	6,467	513	850	-24	4,914	4,609	4,578	-1,551	13,068	30,393	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-246	-5	-	1,379	-22	-121	488	174	-40	-41	2,422	-120	54	3,550	-216	-19	5,389	-188
Impairment of equity investment
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	5,339	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock compensation expense
6,903	7,020	6,818	6,358	6,255	6,151	6,264	5,984	4,927	5,057	4,957	4,684	4,586	4,489	4,750	4,198	3,976	5,741	3,450	3,395	2,399	3,795	3,271	1,965	2,155	1,630	1,866	1,788	1,749	1,687	1,391	1,338	1,261	1,027	918	900	880
Amortization of debt discount, premium and issuance costs
553	2,097	3,143	3,095	3,231	3,267	3,359	3,350	3,136	2,584	2,572	2,552	3,422	3,811	4,768	3,386	3,691	2,797	2,719	2,098	1,929	1,902	1,802	1,798	2,051	1,926	1,919	2,284	2,304	2,072	1,983	1,754	1,757	-	-	-	-
Deferred income taxes
9,364	-188	-957	-6,209	-81	9,309	-401	-1,769	78	-66,198	-4,652	1,951	-3,425	497	198	-9,811	-3,475	4,867	-2,497	-1,957	-2,471	11,467	1,569	1,218	57	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities, net of effects of business combinations:
Amortization of debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	309	455	507
Accounts receivable
53,928	-35,434	7,552	11,121	74,752	-31,080	-29,269	-40,037	45,811	53,883	2,359	22,680	118,269	-70,017	-3,320	4,932	39,164	43,794	-40,487	27,455	61,810	44,878	-31,325	-3,188	87,437	-22,092	5,405	5,869	77,963	-25,665	-20,013	-31,799	62,319	29,660	226	-18,895	100,135
Other current assets
-27	-1,757	-3,220	1,713	7,523	-6,122	7,263	-5,934	8,945	-4,274	-2,880	-2,064	7,621	-5,356	-1,083	-3,451	-7,560	-2,077	-3,458	2,114	5,924	2,220	-3,426	-209	3,144	525	1,748	-513	6,407	-242	237	-2,807	4,419	1,441	-1,751	-1,565	3,076
Other assets
-2,248	-	-	-	-57,319	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-3,029	1,856	9,949	-16,633	2,293	3,214	-4,669	48	-4,144	-638	-5,399	891	-173	-972	-1,905	-1,663	-2,164	-1,195	-476	3,938	273	3,355	-796	652	-4,592	405	1,372	-3,047	3,153	1,652	-672	-2,052
Accounts payable
-8,992	4,374	-1,301	-1,654	4,324	1,729	1,955	1,090	-6,552	-10	3,154	347	412	2,260	-1,900	5,470	-21,322	-702	-5,878	3,593	5,332	3,721	-8,067	5,611	4,732	-8,081	9,463	-6,795	4,130	-2,019	1,388	-3,926	-1,560	6,621	5,901	-3,670	11,777
Accrued expenses
-44,455	14,902	40,552	51,007	-69,163	-21,495	48,184	13,188	-11,981	-1,411	23,585	13,596	-18,429	-6,704	32,364	-30,561	51,193	-25,516	32,009	-6,050	6,757	-16,022	14,069	-1,283	-12,803	1,912	35,881	-7,503	-20,700	19,622	-6,075	27,008	-20,585	17,454	-19,341	16,723	-9,948
Due to third party payors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,320	1,897	-4,808	-1,378	1,253	485	1,277	-586	10	-474
Income taxes
11,413	-	-15,428	-1,484	17,830	-	-3,538	772	11,838	-	-258	3,979	15,420	-	-23,543	9,720	19,370	-	-3,170	-6,500	24,916	-	-3,325	-20,101	19,223	-	8,379	-29,112	21,293	-	1,680	-17,503	27,382	-	17,659	-18,219	26,238
Net cash provided by operating activities
44,084	178,542	133,726	91,152	41,762	113,217	164,027	166,223	50,727	108,159	89,632	96,201	-55,861	65,842	102,523	67,070	111,168	4,984	128,371	37,525	37,535	18,399	110,074	58,169	-16,000	77,418	93,082	33,997	-11,974	104,606	75,271	110,625	8,180	73,214	60,387	88,559	-5,032
Investing activities
Business combinations, net of cash acquired
6,833	7,436	207	79,942	6,120	3,876	1,554	2,345	515,359	8,019	863	8,942	9,566	57,975	-7,288	8,636	412,883	11,756	1,875	1,045,311	2,686	0	757	79	375	-	-	-	-	-	-	-	-	2,820	0	-3,921	2,000
Payments to Acquire Productive Assets
39,208	33,170	34,671	40,212	49,073	46,242	39,391	42,031	39,617	59,443	68,498	54,649	50,653	43,373	38,002	33,490	46,768	68,650	45,080	41,064	27,848	21,896	22,857	23,194	27,299	28,329	17,369	13,963	13,999	22,997	17,254	16,183	11,751	13,922	8,398	10,776	12,920
Proceeds from sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	16,511	0	0	7,629	250
Investment in businesses
9,848	5,422	8,411	24,649	27,608	546	9,645	1,537	1,754	1,308	1,500	9,374	500	1,583	1,550	967	623	644	848	-145	1,000	1,499	2,960	51	124	2,463	3,714	18,739	9,977	4,790	-115	2,174	7,840	-	-	-	-
Proceeds from sale of assets and businesses
11,230	9	58	123	2	69	19	5,981	691	45,795	3	15,040	19,512	-	-	8,766	62,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-44,659	-46,019	-43,231	-144,680	-82,799	-50,595	-50,571	-39,932	-556,039	-22,975	-70,858	-57,925	-41,207	-91,318	-31,001	-34,327	-397,674	-80,825	-13,165	-1,086,230	-31,534	-23,395	-26,574	-23,324	-27,798	-29,215	-21,242	-32,873	-23,976	-32,283	-18,480	-18,563	-3,080	-18,927	-8,398	-12,740	-14,670
Financing activities
Borrowings on revolving facilities
460,000	0	65,000	275,000	360,000	175,000	155,000	100,000	165,000	165,000	175,000	100,000	530,000	155,000	100,000	130,000	190,000	295,000	180,000	445,000	215,000	235,000	160,000	230,000	285,000	110,000	125,000	265,000	190,000	130,000	25,000	110,000	230,000	140,000	160,000	230,000	205,000
Net proceeds from term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	298,500	-	-	-	-	-	-	-	-
Payments on revolving facilities
295,000	0	260,000	240,000	220,000	220,000	240,000	195,000	150,000	255,000	155,000	135,000	415,000	110,000	165,000	205,000	175,000	220,000	275,000	225,000	175,000	215,000	230,000	225,000	200,000	155,000	165,000	250,000	230,000	0	25,000	165,000	215,000	150,000	175,000	290,000	105,000
Proceeds from term loans
-	-	-	-	-	-81	0	0	779,904	0	0	-335	1,139,822	0	195,217	0	600,127	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	26,884	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
39,843	1,243,086	242,399	0	132,685	2,875	2,875	2,875	2,875	2,875	2,875	2,875	1,170,817	872,876	-205,193	-2,687	-226,962	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revolving facility debt issuance costs
-	-	-	-	-	306	0	0	1,333	0	0	505	3,887	-	-	-	-	-	-	-	-	-	0	0	4,434	94	237	14,374	4,209	-	-	-	-	-	-	-	-
Borrowings of other debt
6,487	4,943	5,052	5,940	8,290	-	-	8,328	11,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on credit facility term loans
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	33,994	-	2,053	589,052	3,563	2,812	2,813	2,125	2,125	-	-	-	-
Net proceeds from 6.375% senior notes issuance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,295	0	0	111,650	-	-	-	-	-	-	-	-	-	-	-	-
Payments on 2005 credit facility term loans, net of premium
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	425,070	59,563
Repurchase of senior floating rate notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	167,300	-	-	-	-	-	-	-	-
Repurchase of 7 5/8% senior subordinated notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	70,000	-	-	-	-	-	-	-	-
Borrowings of other debt
-	-	-	-	-	-	-	-	-	19,050	18,127	2,873	6,571	-	1,719	15,355	6,727	2,333	1,451	3,008	6,582	2,040	925	0	6,111	6,072	2,329	1,083	5,826	2,446	0	0	5,835	1,559	0	0	5,496
Principal payments on other debt
8,099	7,976	9,948	6,525	6,155	7,271	6,450	5,612	5,909	5,535	4,675	5,162	5,275	5,924	5,551	5,462	4,464	-	-	3,736	4,584	2,977	4,647	3,982	3,067	3,367	2,794	2,382	2,291	2,878	2,332	2,757	2,328	1,653	2,366	986	2,494
Repurchase of common stock
8,691	1,222	23,689	13,620	0	1,197	4,751	767	122	1,150	3,003	444	156	-	-	-	-	-	-	-	-	1,677	1,557	18,000	109,500	835	963	0	9,983	112	0	21,051	25,739	41,163	28,356	1,259	2,026
Dividends paid to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	13,129	13,109	13,104	13,097	14,056	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	89	13	882	738	383	671	346	617	184	831	636	21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	279	836	489	-	248	3,354	1,943	-	-	-	-	713	557	452	95	39	0	88	81
Equity investment by Holdings
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefit from stock based awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,463	372	6	5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in overdrafts
0	0	-27,259	-3,874	6,050	1,792	-1	1,745	-7,916	10,540	-15,211	11,834	-17,062	19,210	-6,326	26,477	-28,615	4,516	-3,237	8,411	-2,821	-1,064	13,618	-9,284	5,970	5,071	-12,026	7,254	-5,629	4,238	-6,750	1,248	2,491	1,991	-6,276	11,520	-9,418
Dividends paid to Holdings
-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of non-controlling interests
1,679	159	0	14,863	3,425	0	0	2,926	0	996	5,433	1,459	2,094	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of non-controlling interests
-	-	-	-	-	-	-	-	-	-	-	-	-	-	236	0	1,294	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to and purchases of non-controlling interests
12,474	5,748	8,287	2,494	5,251	5,092	5,214	14,572	286,641	1,224	3,740	1,879	3,657	3,456	4,490	1,647	3,061	5,197	3,158	1,857	2,425	860	1,279	388	1,452	465	1,605	422	1,045	271	1,316	583	1,098	1,105	1,237	599	1,671
Purchase of membership interests of Concentra Group Holdings Parent (Note 4)
366,203	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-262,144	67,396	-78,568	29,749	13,674	-47,857	-94,072	-104,945	502,446	-69,935	14,727	-29,688	63,250	56,282	-81,719	-39,731	357,479	67,641	-117,762	1,067,308	-2,767	-2,679	-75,611	-36,397	44,171	-53,177	-71,315	3,144	306	-81,855	-28,635	-79,816	-7,869	-52,457	-55,360	-77,303	30,405
Net decrease in cash and cash equivalents
-262,719	199,919	11,927	-23,779	-27,363	14,765	19,384	21,346	-2,866	15,249	33,501	8,588	-33,818	30,806	-10,197	-6,988	70,973	-8,200	-2,556	18,603	3,234	-7,675	7,889	-1,552	373	-4,974	525	4,268	-35,644	-9,532	28,156	12,246	-2,769	1,830	-3,371	-1,484	10,703
Supplemental Information
Cash paid for interest
67,885	33,902	51,181	60,710	37,199	59,028	37,040	62,105	35,233	47,815	24,691	38,085	38,565	49,712	23,613	47,771	21,544	43,229	20,005	31,197	8,735	31,030	8,675	24,700	14,407	28,622	6,525	26,708	27,206	12,600	35,744	1,093	31,285	12,856	35,343	17,924	41,365
Cash paid for taxes
1,135	12,120	29,231	28,523	718	7,693	17,980	22,104	376	18,438	18,927	26,419	1,207	10,819	24,419	34,309	1,209	23,515	23,203	31,969	733	12,587	19,713	42,659	2,812	11,986	6,145	45,692	1,140	17,764	14,506	45,140	204	7,895	1,670	29,332	103
Operating lease right-of-use assets obtained in exchange for lease liabilities, excluding adoption impact of ASC Topic 842 at January 1, 2019
67,894	-	-	-	24,176	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Select Medical Corporation
Net income
-	-	-	-	-	-	42,679	60,559	43,982	121,058	24,824	51,300	23,463	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated subsidiaries
-	-	-	-	-	-	2,904	6,466	1,364	5,464	3,609	6,022	4,911	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation, Depletion and Amortization, Nonproduction
-	-	-	-	-	-	50,527	51,724	46,771	40,367	38,772	38,333	42,539	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
-	-	-	-	-	-	-475	17	85	78,577	169	-36	781	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (Loss) from Equity Method Investments
-	-	-	-	-	-	5,432	4,785	4,697	5,436	4,431	5,666	5,521	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-	0	72	412	0	0	0	6,527	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of assets and businesses
-	-	-	-	-	-	2,149	6,467	513	-	-24	4,914	4,609	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock compensation expense
-	-	-	-	-	-	6,264	5,984	4,927	5,057	4,957	4,684	4,586	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount, premium and issuance costs
-	-	-	-	-	-	3,359	3,350	3,136	2,584	2,572	2,552	3,422	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-401	-1,769	78	-66,198	-4,652	1,951	-3,425	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-29,269	-40,037	45,811	53,883	2,359	22,680	118,269	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other current assets
-	-	-	-	-	-	7,263	-5,934	8,945	-4,274	-2,880	-2,064	7,621	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	1,856	9,949	-16,633	2,293	3,214	-4,669	48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
-	-	-	-	-	-	1,955	1,090	-6,552	-10	3,154	347	412	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses
-	-	-	-	-	-	48,184	13,188	-11,981	-1,411	23,585	13,596	-18,429	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes
-	-	-	-	-	-	-3,538	772	11,838	-	-258	3,979	15,420	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
-	-	-	-	-	-	164,027	166,223	50,727	108,159	89,632	96,201	-55,861	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business combinations, net of cash acquired
-	-	-	-	-	-	1,554	2,345	515,359	8,019	863	8,942	9,566	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
-	-	-	-	-	-	39,391	42,031	39,617	59,443	68,498	54,649	50,653	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in businesses
-	-	-	-	-	-	9,645	1,537	1,754	1,308	1,500	9,374	500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of assets and businesses
-	-	-	-	-	-	19	5,981	691	45,795	3	15,040	19,512	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-50,571	-39,932	-556,039	-22,975	-70,858	-57,925	-41,207	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings on revolving facilities
-	-	-	-	-	-	155,000	100,000	165,000	165,000	175,000	100,000	530,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on revolving facilities
-	-	-	-	-	-	240,000	195,000	150,000	255,000	155,000	135,000	415,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from term loans
-	-	-	-	-	-	0	0	779,904	0	0	-335	1,139,822	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on term loans
-	-	-	-	-	-	2,875	2,875	2,875	2,875	2,875	2,875	1,170,817	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revolving facility debt issuance costs
-	-	-	-	-	-	0	0	1,333	0	0	505	3,887	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings of other debt
-	-	-	-	-	-	10,206	8,328	11,600	19,050	18,127	2,873	6,571	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Principal payments on other debt
-	-	-	-	-	-	6,450	5,612	5,909	5,535	4,675	5,162	5,275	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of common stock
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	-	-	-	-	-	-	156	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity investment by Holdings
-	-	-	-	-	-	13	882	738	383	671	346	617	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in overdrafts
-	-	-	-	-	-	-1	1,745	-7,916	10,540	-15,211	11,834	-17,062	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid to Holdings
-	-	-	-	-	-	4,751	767	122	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of non-controlling interests
-	-	-	-	-	-	0	2,926	0	996	5,433	1,459	2,094	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to and purchases of non-controlling interests
-	-	-	-	-	-	5,214	14,572	286,641	1,224	3,740	1,879	3,657	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-94,072	-104,945	502,446	-69,935	14,727	-29,688	63,250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	19,384	21,346	-2,866	15,249	33,501	8,588	-33,818	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	37,040	62,105	35,233	47,815	24,691	38,085	38,565	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for taxes
-	-	-	-	-	-	17,980	22,104	376	18,438	18,927	26,419	1,207	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-